Minutes - Medication WG 2024-01-28

From Health Level 7 Belgium Wiki
Attendees
  • Bart Rondou
  • Hendrik Janssen (technical lead recip-e at Smals)
  • Ilse Dossche
  • Jacques Yakoub
  • Jan Lenie
  • José Costa Teixeira
  • Karlien Erauw
  • Kristof Gentens
  • Loïc Carlier
  • Philippe Baise
  • Ruben Walraevens
  • Thomas Van Langendonck
Excused/Not present
  • Alexis Van Zeveren
  • Annabel Dompas
  • Annemieke Vergauwe
  • Anne Nerenhausen
  • Bart Decuypere
  • Félix De Tavernier
  • Hanne Vuegen
  • Hans De Keersmaecker
  • Jean-Michel Polfliet
  • Jens Penny
  • Katrien Thorré
  • Marc Buckens
  • Marcelo Romero-Cors
  • Michel Demey
  • Mike Shoop
  • Nathan Peeters
  • Nick Hermans
  • Nils D'hont
  • Pablo Christiaens
  • Stephane Bouillon
  • Thomas Van Langendonck
  • Tom Henkens
  • Werner De Mulder
  • Walter Bollaert
  • Will van Norel
Agenda
  • Medication prescription in FHIR: resolution of issues & feedback on business rules
Minutes
  • Reminder: the business document has been shared with us 3 weeks ago by INAMI/RIZIV, see here
  • Main branch is to publish the medication line
  • What are the open issues ?
  • when can we expect the Dutch version
  • terminology: open questions
  • issue 230, 231, 222
  • issue 216 has plenty of remarks on the business documents
  • we have proposed some changes but we need discussion/confirmation by RIZIV
  • We go over the profile of the Medication Prescription logical model
  • here we await input from RIZIV
  • it is based on medication line
  • medication has to point to terminology, which is also open
  • dosage: dosageOverride
  • SAMv2 only provides textual information
  • there is no automated indication in place yet when do
  • noSubstition: currently in kmehr it is called substitution allowed so it will be changed in the FHIR logical model
  • interval b/w dispenses: is not present in FHIR profile yet
  • in Belgium it is in place yet
  • grouping of requests
  • terminology: requests have to be requested to NRC, which can take up hours or months
  • do we want to include the valuesets in the FHIR profile ?
  • process on this is being discussed, as it would be useful to not having to
  • naming system: has to be followed up in the FHIR validation team meeting
  • notion of temporality exists in kmehr, to check if this will be added in FHIR
  • Where will the terminologies come from for medication: SAMv2 will provide these: VMP, AMPP
  • CTI-extended has been proposed, so wondering why this has been chosen over CNK --> please add to issue
  • No update on workflows: this and task are under discussion in the European group, see here and here
  • INAMI/RIZIV business document state that Adherence is mandatory with default to "unknown" as we want to follow up if medication is being taken
  • this is being questioned, comments are added


* Action items:

  • to check with RIZIV on the progress of the open issues
  • to be able to complete the review of logical model and its alignment with the business document & resolve issues


Next meeting: Tuesday 18 February at 11AM